JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 7, 2008, 10.2967/jnumed.108.053397
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.053397v1
49/12/1973    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eary, J. F.
Right arrow Articles by Conrad, E. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eary, J. F.
Right arrow Articles by Conrad, E. U.
Journal of Nuclear Medicine Vol. 49 No. 12 1973-1979
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.108.053397

Clinical Investigation

Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome

Janet F. Eary1, Finbarr O'Sullivan2, Janet O'Sullivan2 and Ernest U. Conrad1

1 Division of Nuclear Medicine, Departments of Radiology and Orthopedic Surgery, University of Washington, Seattle, Washington; and 2 Department of Statistics, University College Cork, Cork, Ireland

Correspondence: For correspondence or reprints contact: Janet F. Eary, University of Washington, University of Washington Medical Center, 1959 NE Pacific St., Room NW041, Box 356004, Seattle, WA 98195-6004. E-mail: jeary{at}u.washington.edu

18F-FDG PET images of tumors often display highly heterogeneous spatial distribution of 18F-FDG–positive pixels. We proposed that this heterogeneity in 18F-FDG spatial distribution can be used to predict tumor biologic aggressiveness. This study presents data to support the hypothesis that a new heterogeneity-analysis algorithm applied to 18F-FDG PET images of tumors in patients is predictive of patient outcome. Methods: 18F-FDG PET images from 238 patients with sarcoma were analyzed using a new algorithm for heterogeneity analysis in tumor 18F-FDG spatial distribution. Patient characteristics, tumor histology, and patient outcome were compared with image analysis results using univariate and multivariate analysis. Cox proportional hazards models were used to further analyze the significance of the data associations. Results: Statistical analyses show that heterogeneity analysis is a strong independent predictor of patient outcome. Conclusion: The new 18F-FDG PET tumor image heterogeneity analysis method is validated for the ability to predict patient outcome in a clinical population of patients with sarcoma. This method can be extended to other PET image datasets in which heterogeneity in tissue uptake of a radiotracer may predict patient outcome.

Key Words: 18F-FDG • PET • sarcoma • image analysis

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
RadioGraphicsHome page
M. E. Lee
Invited Commentary
RadioGraphics, September 1, 2009; 29(5): 1500 - 1501.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.